When putting together your watch list, focus on stocks with an 80 or higher RS Rating. Bio-Rad Labs A is one stock that just reached the mark, now earning a score of 82.
This exclusive rating from Investor's Business Daily tracks share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
While Bio-Rad Labs A is not near an ideal entry right now, see if it goes on to form and break out from a proper consolidation.
While earnings growth decreased in the company's most recent performance report from 4% to -14%, revenue grew 3%, up from -6% in the prior report.
The company holds the No. 4 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
